Survey to identify Mycobacterium leprae-infected household contacts of patients from prevalent regions of leprosy in Colombia

Memorias do Instituto Oswaldo Cruz

Volumn 103, Issue 4, 2008, Pages 332-336

  Cardona Castro, N ^a   Beltran Alzate J C ^b   Manrique Hernandez R ^b  

^a Instituto Colombiano de Medicina Tropical   (Colombia)

^b UNIVERSIDAD CES   (Colombia)

Author keywords

Household contacts; IgM anti PGL 1; Leprosy; Mitsuda reaction; Mycobacterium leprae

Indexed keywords

MYCOBACTERIUM LEPRAE;

EID: 47749143228     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/S0074-02762008000400003     Document Type: Article

References (29)

1. Amezcua ME, Escobar-Gutierrez A, Mayen E, Cazares JV 1987. Sensitivity and specificity of the FLA-ABS test for leprosy in Mexican populations. Int J Lepr Other Mycobact Dis 55: 286-292.
2. Beyene D, Aseffa A, Harboe M, Kidane D, Macdonald M, Klatser PR, Bjune GA, Smith WC 2003. Nasal carriage of Mycobacterium leprae DNA in healthy individuals in Lega Robi village, Ethiopy. Epidemiol Infect 131: 841-848.
3. Buhrer-Sekula S, Sarno EN, Oskam L, Koop S, Wichers I, Nery JA, Vieira LM, de Matos HJ, Faber WR, Klatser PR 2000. Use of ML dipstick as a tool to classify leprosy patients. Int J lepr Other Mycobact Dis 68: 456-463.
4. Cardona-Castro N, Restrepo-Jaramillo S, Gil de la Ossa M, Brennan P 2005. Infection by Mycobacterium leprae of household contacts of lepromatous leprosy patients from a post-elimination leprosy region of Colombia. Mem Inst Oswaldo Cruz 100: 703-707.
5. Chanteau S, Glaziou P, Plichart C, Luquiaud P, Plichart R, Faucher JF, Cartel JL 1993. Low predictive value of PGL-I serology for the early diagnosis of leprosy in family contacts: results of a 10-year prospective field study in French Polynesia. Int J Lepr Other Mycobact Dis 61: 533-541.
6. Cho SN, Yanagihara DL, Hunter SW, Gelber RH, Brennan PJ 1983. Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy. Infect Immun 41:1077-1083.
7. Feitosa M, Krieger H, Borecki I, Beiguelman B, Rao DC 1996. Genetic epidemiology of the Mitsuda reaction in leprosy. Hum Hered 46: 32-35.
8. Geluk A, van der Ploeg J, Teles RO, Franken KL, Prins C, Drijfhout JW, Sarno EN, Sampaio EP, Ottenhoff TH 2008. Rational combination of peptides derived from different M. leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection. Clin Vaccine Immunol 15: 522-533.
9. Groathouse NA, Rivoire B, Hansuk K, Hyeyoung L, Cho SN, Brennan PJ, Vissa VD 2004. Multiple polymorphic loci for molecular typing of strains of Mycobacterium leprae. J Clin Microbiol 42: 1666-1672.
10. Gupta V, Bhushan K, Dogra S, Vasudev U, Kaur I 2004. Leprosy elimination - How far? Lep Rev 75: 101-102.
11. Jadhav RS, Macdonald M, Bjune G, Oskam L, MILEP2 Study Group 2001. Simplified PCR detection method from nasal Mycobacterium leprae. Int J Lepr Other Mycobact Dis 69: 299-307.
12. Job CK, Jayakumar J, Williams DL, Gillis TP 1997. Role of polymerase chain reaction in the diagnosis of early leprosy. Int J Lepr 65: 461-464.
13. Kalk A, Fleisher K 2004. The decentralization of the health system in Colombia and Brazil and its impact on leprosy control. Lepr Rev 75: 67-68.
14. Lockwood DN 2002. Leprosy elimination - a virtual phenomenon or a reality? BMJ 324: 1516-1518.
15. Lockwood DNJ, Kumar B 2004. Treatment of leprosy. BMJ 328: 1447-1448.
16. Meeker HC, Levis WR, Sersen E, Schuller-Levis G, Brennan PJ, Buchanan TM 1986. ELISA detection of IgM antibodies against phenolic glycolipid-I in the management of leprosy: a comparison between laboratories. Int J Lepr Other Mycobact Dis 54: 530-539.
17. Meima A, Smith WCS, van Ootmarssen GJ, Richardus JH, Habbema DF 2004. The future incidence of leprosy: a scenario analysis. Bull World Health Organ 5: 373-380.
18. Mitsuda K 1953. On the value of a skin reaction to a suspension of leprous nodules. Int J Lepr 21: 347-350.
19. Mora N, Pérez M, Beroliche M 1992. Determinación de anticuerpos anti-glicolípido fenólico I en población general de una área endémica de lepra. Fontilles Rev Leprol 6: 587-589.
20. Naafs B 2000. Viewpoint: leprosy after the year. Trop Med Int Health 5: 400-403.
21. Oskam L, Slim E, Bührer-Sékula S 2003. Serology: recent developments, strengths, limitations and prospects: a state of the art overview. Lepr Rev 74: 196-205.
22. Parkash O, Kumar A, Nigam A, Franken KL, Ottenhoff TH 2006. Evaluation of recombinant serine-rich 45-kDa antigen (ML0411) for detection of antibodies in leprosy patients. Scand J Immunol 64: 450-455.
23. Parkash O, Kumar A, Pandey R, Franken KL, Ottenhoff TH 2007. Detection of Mycobacterium leprae infection employing a combinatorial approach of anti-45 kDa and modified anti-PGL-I antibody detection assays. J Med Microbiol 56: 1129-1130.
24. Scollard DM, Gillis TP, Williams DL 1998. Polymerase chain reaction assay for the detection and identification of Mycobacterium leprae in patients in the United States. Am J Clin Pathol 109: 642-646.
25. Sengupta U 2000. Experience and lessons from the use of lepromin and Mycobacterium leprae-specific serology. Lepr Rev 71: S63-66.
26. Torres P, Camarena JJ, Gomez JR, Nogueira JM, Gimeno V, Navarro V, Navarro JC, Olmos A 2003. Comparison of PCR mediated amplification of DNA and the classical methods for detection of Mycobacterium leprae in different types of clinical samples in leprosy patients and contacts. Lepr Rev 74: 18-30.
27. Van Beers SM, Izumi S, Madjid B, Maeda Y, Day R, Klatser PR 1994. An epidemiological study of leprosy infection by serology and polymerase chain reaction. Int J Lepr Other Mycobact Dis 62: 1-9.
28. Visschedijk J, van de Broek, Eggens H, Lever P, van Beers S, Klatser P 2000. Mycobacterium leprae-millennium resistant! Leprosy control on the threshold of a new era. Trop Med Int Health 5: 388-399.
29. Wu Q, Li X, Yin Y, Shu H, Wei W, Liu Q, Ye G 1999. A study on the methods for early serological diagnosis of leprosy and their potential use. Int J Lepr Other Mycobact Dis 67: 302-305.